Search

Your search keyword '"Averkov, O."' showing total 106 results

Search Constraints

Start Over You searched for: Author "Averkov, O." Remove constraint Author: "Averkov, O."
106 results on '"Averkov, O."'

Search Results

2. Model for predicting risk of developing drug-induced liver injury during remdesivir therapy: observational prospective open case-control study

3. Cytokines in predicting JAK inhibitors clinical efficacy for COVID-19

4. Evaluation of the association of CES1 (rs2244613) polymorphisms with the safety of remdesivir in hospitalized patients with COVID-19

5. Safety of Pharmacotherapy in COVID-19 Patients: A Literature Review

9. Dapagliflozin and cardiovascular outcomes in type 2 diabetes

11. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

19. Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients

21. Place of Prasugrel, P2Y12 receptor antagonist, in an early invasive treatment of patients with acute coronary syndrome (according to the results of multicenter randomized controlled trial ISAR-REACT 5)

24. Differentiated approach in diagnostics, diagnosis formulation, case management and statistical accounting of type 2 myocardial infarction (Position Paper)

26. Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely III Medical Patients: An APEX Trial Substudy

28. The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial

29. Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients

30. Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

33. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

34. Extended thromboprophylaxis with betrixaban in acutely ill medical patients

40. Intravenous NPA for the treatment of infarcting myocardium early; InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction

Catalog

Books, media, physical & digital resources